000 | 01684 a2200445 4500 | ||
---|---|---|---|
005 | 20250518041345.0 | ||
264 | 0 | _c20200929 | |
008 | 202009s 0 0 eng d | ||
022 | _a1943-0264 | ||
024 | 7 |
_a10.1101/cshperspect.a035196 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDistelhorst, Clark W | |
245 | 0 | 0 |
_aCreating a New Cancer Therapeutic Agent by Targeting the Interaction between Bcl-2 and IP _h[electronic resource] |
260 |
_bCold Spring Harbor perspectives in biology _c09 2019 |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBridged Bicyclo Compounds, Heterocyclic _xpharmacology |
650 | 0 | 4 | _aCalcium Signaling |
650 | 0 | 4 | _aCell Death |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 | _aCell Survival |
650 | 0 | 4 |
_aEndoplasmic Reticulum _xmetabolism |
650 | 0 | 4 | _aFeedback, Physiological |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmune System |
650 | 0 | 4 |
_aInositol 1,4,5-Trisphosphate Receptors _xmetabolism |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 | _aProtein Domains |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aSulfonamides _xpharmacology |
700 | 1 | _aBootman, Martin D | |
773 | 0 |
_tCold Spring Harbor perspectives in biology _gvol. 11 _gno. 9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1101/cshperspect.a035196 _zAvailable from publisher's website |
999 |
_c29711257 _d29711257 |